Several studies have demonstrated that IL-17A possesses pro-fibrotic properties in both human and SSc animal models [17,21,65,66,69,71,72]; however, there are some contradictory findings in humans [66,71]. This evidence concerns the gene IL17A and systemic sclerosis.